Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients
Launched by CRG UZ BRUSSEL · Jun 9, 2020
Trial Information
Current as of June 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Undergoing IVF/ICSI treatment
- • Planned for an oocyte retrieval
- • PCR positive of SARS-CoV-2 or high suspicion for COVID 19 based on CT scan
- • Signed informed consent
- Exclusion Criteria:
- • None
About Crg Uz Brussel
CRG UZ Brussel is a leading clinical trial sponsor based in Brussels, Belgium, dedicated to advancing medical research and enhancing patient care through innovative clinical studies. Affiliated with a prominent academic hospital, CRG UZ Brussel leverages its expertise in diverse therapeutic areas to conduct rigorous research that adheres to the highest ethical and scientific standards. Committed to fostering collaboration among healthcare professionals, researchers, and industry partners, CRG UZ Brussel aims to translate scientific discoveries into effective treatments, ultimately improving health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials